Blog
RSS FeedPosted by Michael Wonder on 06 Jun 2023
‘Future of cancer treatment’ has just been approved
6 June 2023 - Australian scientists pioneering a new type of therapy, which re-engineers a patient’s own T-cells, could result in ...
Posted by Michael Wonder on 04 Jul 2022
Report on 'Cell, Gene and Tissue Regulatory Framework in Australia: Stakeholder Perspectives' - TGA response
4 July 2022 - n November 2021 the TGA commissioned MTP Connect to conduct a stakeholder review of the regulatory ...
Posted by Michael Wonder on 07 Apr 2021
TGA to review advertising of stem cell therapies to the Australian public
7 April 2021 - The Therapeutic Goods Administration, part of the Department of Health, is investigating the advertising of stem ...
Posted by Michael Wonder on 02 Sep 2020
TGA announces it has approved Yescarta
2 September 2020 - Announcement in September of a decision made in February. ...
Posted by Michael Wonder on 24 Apr 2020
Mesoblast claims coronavirus treatment breakthrough
24 April 2020 - Stem cell-focused biotech Mesoblast has claimed a breakthrough in its experimental therapy to treat patients with ...
Posted by Michael Wonder on 18 Dec 2018
Revolutionary' cancer drug using genetically modified cells approved
19 December 2018 - A revolutionary cancer therapy that supercharges a patient's immune cells to hunt and destroy cancer cells ...
Posted by Michael Wonder on 06 Jun 2016
TGA publishes 2 new AusPARs
6 June 2016 - The TGA has published AusPARs for talimogene laherparepvec (Imlygic) & naloxegol oxalate (Movantik). ...
Posted by Michael Wonder on 04 Apr 2016
TGA consultation forecast
4 April 2016 - The consultation forecast provides an indication of the major consultations scheduled by the TGA for release during ...